Holen Sie sich die Stockscreener-App
69.59
3.90%
2.61
Handel nachbörslich:
69.59
Exact Sciences Corp Aktie (EXAS) Neueste Nachrichten
Key facts: Exact Sciences Q3 Revenue Hits $850.7M; Cancerguard Launched; Analysts Raise Price Targets - TradingView
EXAS: TD Cowen Raises Price Target to $90 on Buy Rating | EXAS S - GuruFocus
Exact Sciences (EXAS) Receives Updated Analyst Rating from Baird - GuruFocus
EXAS: Benchmark Raises Price Target to $75 in Latest Analyst Rev - GuruFocus
EXAS: Guggenheim Raises Price Target to $75 While Maintaining Bu - GuruFocus
Stifel raises Exact Sciences stock price target to $80 on strong Cologuard growth - Investing.com
EXAS: Barclays Raises Price Target to $77, Maintains Overweight Rating | EXAS Stock News - GuruFocus
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results - Benzinga
Madison-based Exact Sciences reports Q3 results topping analysts’ expectations - Wisconsin State Journal
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth - Yahoo! Finance Canada
EXAS: Stifel Raises Target Price to $80, Maintains Buy Rating | - GuruFocus
Can Exact Sciences Corporation (EXK) stock stage a strong rebound this quarterJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
BTIG Raises Price Target for Exact Sciences (EXAS) to $85 | EXAS Stock News - GuruFocus
Exact Sciences stock price target raised to $85 from $75 at BTIG - Investing.com
Exact Sciences to Participate in November Investor Conference - Bluefield Daily Telegraph
How Intuitive Surgical Stock Gained 19.5% Last Month - AOL.com
Exact Sciences Corporation stock chart pattern explained2025 AllTime Highs & Daily Profit Focused Screening - newser.com
Exact Sciences: Q3 Earnings Snapshot - New Haven Register
Canaccord Genuity raises Exact Sciences stock price target to $85 on strong growth - Investing.com
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus
Exact Sciences Corp (EXAS) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo! Finance UK
Exact Sciences Reports Record Q3 Revenue and Raises Guidance - TipRanks
Transcript : Exact Sciences Corporation, Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Exact Sciences Q3 2025 slides: 20% revenue growth, guidance raised - Investing.com
Earnings call transcript: Exact Sciences beats Q3 2025 EPS forecasts - Investing.com
EXACT SCIENCES CORP SEC 10-Q Report - TradingView
Exact Sciences Corp (EXAS) Q3 2025 Earnings: Revenue Surpasses E - GuruFocus
Exact Sciences stock higher after beating Q3 expectations, raising guidance By Investing.com - Investing.com South Africa
Exact Sciences Announces Third Quarter 2025 Results - Stock Titan
What candlestick patterns are forming on Exact Sciences CorporationGlobal Markets & Entry Point Confirmation Signals - newser.com
Exact Sciences (EXAS) Q3 Earnings Preview: Positive Revisions Bo - GuruFocus
Exact Sciences Corporation Stock (EXAS) Opinions on Upcoming Earnings and Clinical Data - Quiver Quantitative
Should You Buy Exact Sciences Stock Before Nov. 3? - MSN
Nisa Investment Advisors LLC Acquires 4,500 Shares of Exact Sciences Corporation $EXAS - MarketBeat
How New Developments Are Shaping the Analyst Story for Exact Sciences - Yahoo Finance
Exact Sciences (EXAS) Reports Q3: Everything You Need To Know Ahead Of Earnings - Yahoo! Finance UK
Exact Sciences Corporation (EXAS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
EXACT SCIENCES Earnings Preview: Recent $EXAS Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Exact Sciences Corporation $EXAS Shares Sold by Jennison Associates LLC - MarketBeat
Brighton Jones LLC Takes $366,000 Position in Exact Sciences Corporation $EXAS - MarketBeat
KLCM Advisors Inc. Invests $212,000 in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences pulls out of major expansion project near Phoenix Sky Harbor - azcentral.com and The Arizona Republic
Exact Sciences’ MCED Test Study: A Potential Game-Changer in Early Cancer Detection - MSN
Exact Sciences’ Latest Study on Breast Cancer Recurrence Detection: A Potential Game Changer - MSN
69,932 Shares in Exact Sciences Corporation $EXAS Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Why Exact Sciences Corporation stock could see breakout soon2025 Market Trends & Expert Curated Trade Ideas - newser.com
Can Exact Sciences Corporation (EXK) stock hit consensus price targetsWeekly Trend Report & Accurate Intraday Trading Signals - newser.com
One-on-One with David Harding of Exact Sciences - Modern Healthcare
A Look at Exact Sciences’s Valuation as New Cancer Screening Advances Debut at Major Gastroenterology Meeting - Yahoo Finance
Zanotti of Exact Sciences sells $780k in stock By Investing.com - Investing.com UK
Leading vs lagging indicators on Exact Sciences Corporation performance2025 Performance Recap & Real-Time Chart Breakout Alerts - newser.com
Exact Sciences presents new colorectal cancer screening data at ACG By Investing.com - Investing.com Philippines
Is Exact Sciences Corporation stock a buy in volatile markets2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Insider Sell: Katherine Zanotti Sells 12,000 Shares of Exact Sci - GuruFocus
Zanotti of Exact Sciences sells $780k in stock - Investing.com
[Form 4] EXACT SCIENCES CORP Insider Trading Activity - Stock Titan
Exact Sciences Corp Director Katherine S Zanotti Sells 12,000 Shares - TradingView
Exact Sciences (MEX:EXAS) Other Stockholders Equity : MXN-0 Mil (As of Jun. 2025) - GuruFocus
0.45%
6.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):